Opportunity
SAM #75N98026Q00493
Procurement of Bio-Rad CFX Opus 96 Real-Time PCR System for NIH Cancer Research Laboratory
Buyer
NIH Office of Logistics and Acquisition Operations
Posted
June 01, 2026
Respond By
June 11, 2026
Identifier
75N98026Q00493
NAICS
334516
This procurement opportunity is issued by the National Institutes of Health (NIH), specifically the National Cancer Institute (NCI), Center for Cancer Research (CCR), Laboratory of Receptor Biology and Gene Expression Branch (LRBGE). - Government Buyer: - U.S. Department of Health and Human Services - National Institutes of Health - National Cancer Institute, Center for Cancer Research, Laboratory of Receptor Biology and Gene Expression Branch - OEM Highlight: - Bio-Rad Laboratories, Inc. is the sole Original Equipment Manufacturer (OEM) specified - Products Requested: - Bio-Rad CFX Opus 96 Real-Time PCR System - 96-well, 5-color plus FRET, network-connected real-time PCR detection platform - Supports gene expression analysis, assay optimization, plate setup, data collection, statistical analysis, and graphing - Quantity: 1 unit - No specific part number provided - Notable Requirements: - System is intended for advanced gene expression analysis and cancer research workflows - Place of performance is the laboratory of Dr. Thomas Misteli - Small businesses are encouraged to submit capability statements - No additional products or services are listed; procurement is for a single, specialized instrument
Description
Attachment: Notice of Intent